78.35
price up icon2.65%   2.02
 
loading

Cvs Health Corp 주식(CVS)의 최신 뉴스

pulisher
04:47 AM

CVS Health Stock at a Crossroads: Value Trap or Quiet Turnaround Story? - AD HOC NEWS

04:47 AM
pulisher
Feb 07, 2026

Should You Buy CVS Health Stock Before Feb. 10? - The Motley Fool

Feb 07, 2026
pulisher
Feb 06, 2026

CVS (CVS) Accepts TrumpRx Discount Cards for Prescription Drugs - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

CVS Health (CVS) Embraces TrumpRx Discount Cards for Medication Savings - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

CVS Pharmacy now accepting TrumpRx discount cards - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

TrumpRx drug discounts now available at 9,000 CVS pharmacies - stocktitan.net

Feb 06, 2026
pulisher
Feb 06, 2026

CVS Expands Biosimilar Access to Lower Drug Costs - intellectia.ai

Feb 06, 2026
pulisher
Feb 06, 2026

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder - Benzinga

Feb 06, 2026
pulisher
Feb 06, 2026

CVS Specialty brings empathy and expertise to fertility patients - CVS Health

Feb 06, 2026
pulisher
Feb 06, 2026

A Look Into CVS Health Inc's Price Over Earnings - Benzinga

Feb 06, 2026
pulisher
Feb 05, 2026

CVS Faces Medicaid Network Loss And PBM Scrutiny As Valuation Looks Undemanding - simplywall.st

Feb 05, 2026
pulisher
Feb 05, 2026

Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey - CVS Health

Feb 05, 2026
pulisher
Feb 05, 2026

Why Press Ganey named Aetna its first Health Plan of the Year - stocktitan.net

Feb 05, 2026
pulisher
Feb 05, 2026

CVS Health (CVS) Expands Biosimilar Offerings to Cut Costs - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

CVS Health to swap Amgen and Lilly’s bone drugs with biosimilars in commercial formularies - Seeking Alpha

Feb 05, 2026
pulisher
Feb 05, 2026

CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists - Reuters

Feb 05, 2026
pulisher
Feb 05, 2026

Is CVS Health Stock a Bad-News Buy? - AOL.com

Feb 05, 2026
pulisher
Feb 05, 2026

UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start—PBM 'Spread Pricing' Comes Under Fire - Yahoo Finance

Feb 05, 2026
pulisher
Feb 05, 2026

New CVS drug list swaps Prolia for cheaper osteoporosis shots - stocktitan.net

Feb 05, 2026
pulisher
Feb 05, 2026

Aetna launches simplified, digital-first, benefits onboarding experience for members in 2026 - CVS Health

Feb 05, 2026
pulisher
Feb 05, 2026

How Aetna’s new texting tools boosted member engagement 80%+ - stocktitan.net

Feb 05, 2026
pulisher
Feb 04, 2026

CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance Australia

Feb 04, 2026
pulisher
Feb 04, 2026

Cigna settles FTC insulin case, aims to lower drug prices - WTAQ

Feb 04, 2026
pulisher
Feb 04, 2026

Express Scripts Reaches Deal With FTC Over Insulin Pricing Practices - PYMNTS.com

Feb 04, 2026
pulisher
Feb 04, 2026

Cigna settles FTC insulin case, commits to overhauling drug pricing - CNBC

Feb 04, 2026
pulisher
Feb 04, 2026

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Feb 04, 2026
pulisher
Feb 04, 2026

UNH Stock: The Factors Behind UnitedHealth's Struggles in Its Recovery - intellectia.ai

Feb 04, 2026
pulisher
Feb 04, 2026

Exclusive: Cigna settles FTC insulin case, aims to lower drug prices - Reuters

Feb 04, 2026
pulisher
Feb 04, 2026

Four drugs to watch in 2026 that could reshape treatment options - CVS Health

Feb 04, 2026
pulisher
Feb 04, 2026

Wegmans, CVS add SNAP/EBT payments on DoorDash - NJBIZ

Feb 04, 2026
pulisher
Feb 03, 2026

Exclusive-Cigna settles FTC insulin case, commits to overhauling drug pricing - Bitget

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Health: Exploit The Sector Panic Ahead Of Earnings (NYSE:CVS) - Seeking Alpha

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy? - Finviz

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Health’s (CVS) Path Forward: Policy Challenges, Analyst Views, and Dividend Stability - Insider Monkey

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Health's (CVS) Path Forward: Policy Challenges, Analyst Views, and Dividend Stability - Finviz

Feb 03, 2026
pulisher
Feb 03, 2026

CVS Pharmacy: How America’s Most Convenient Drugstore Quietly Became a Daily-Life Lifesaver - AD HOC NEWS

Feb 03, 2026
pulisher
Feb 02, 2026

Shorts Report: How does CVS Health Corporation correlate with Nasdaq2025 Winners & Losers & Free Technical Pattern Based Buy Signals - baoquankhu1.vn

Feb 02, 2026
pulisher
Jan 31, 2026

CVS Health Corporation (CVS) Positioned for Long-Term Growth Amid Policy Shifts - Finviz

Jan 31, 2026
pulisher
Jan 31, 2026

CVS Health Faces Antitrust Scrutiny As Valuation Flags Undervaluation Risk - Yahoo Finance UK

Jan 31, 2026
pulisher
Jan 31, 2026

Argus Trims CVS Health (CVS) PT to $90 Amid Medicare Advantage Rate Uncertainty - Finviz

Jan 31, 2026
pulisher
Jan 31, 2026

National Pension Service Purchases 119,189 Shares of CVS Health Corporation $CVS - MarketBeat

Jan 31, 2026
pulisher
Jan 30, 2026

Looking Into CVS Health Corp's Recent Short Interest - Benzinga

Jan 30, 2026
pulisher
Jan 30, 2026

AustralianSuper Pty Ltd Sells 492,309 Shares of CVS Health Corporation $CVS - MarketBeat

Jan 30, 2026
pulisher
Jan 30, 2026

AE Wealth Management LLC Has $19.39 Million Stock Position in CVS Health Corporation $CVS - MarketBeat

Jan 30, 2026
pulisher
Jan 29, 2026

US Labor Department proposes rule to boost transparency in pharmacy benefit manager fees - AOL.com

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Health Corporation $CVS Shares Sold by New York State Common Retirement Fund - MarketBeat

Jan 29, 2026
pulisher
Jan 29, 2026

Novare Capital Management LLC Has $398,000 Stake in CVS Health Corporation $CVS - MarketBeat

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Health Corporation $CVS Shares Sold by Bank of New York Mellon Corp - MarketBeat

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Health and Merck Stocks Undervalued, 2026 Revenue Guidance of $400 Billion - Intellectia AI

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Health Corporation (NYSE:CVS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 29, 2026
pulisher
Jan 29, 2026

CVS Pharmacy Review 2026: Why This Everyday Drugstore Is Quietly Becoming a Health Hub - AD HOC NEWS

Jan 29, 2026
pulisher
Jan 28, 2026

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Jan 28, 2026
pulisher
Jan 28, 2026

CVS Antitrust Allegations Test Pharmacy Model And Long Term Turnaround - simplywall.st

Jan 28, 2026
pulisher
Jan 28, 2026

CVS stock rebounds after Medicare Advantage rate shock; what investors watch next - TechStock²

Jan 28, 2026
pulisher
Jan 28, 2026

CVS Health (CVS) Addresses Fertility Coverage for LGBTQ+ Nationw - GuruFocus

Jan 28, 2026
pulisher
Jan 28, 2026

CVS Health Corp. (CVS) technical analysisCVS Health (NYSE:CVS) - Benzinga

Jan 28, 2026
pulisher
Jan 28, 2026

CVS stock rebounds after Medicare Advantage rate scare; what investors watch next - TechStock²

Jan 28, 2026
pulisher
Jan 28, 2026

UnitedHealth Flags Margin Stress, Pushing Investors Toward Broader Healthcare ETFs - Benzinga

Jan 28, 2026
pulisher
Jan 28, 2026

CVS Health (CVS) Receives Maintained 'Buy' Rating with Adjusted Price Target | CVS Stock News - GuruFocus

Jan 28, 2026
pulisher
Jan 28, 2026

CVS Health (NYSE:CVS) Price Target Cut to $90.00 by Analysts at Argus - MarketBeat

Jan 28, 2026
pulisher
Jan 28, 2026

The CVS Turnaround: A 2026 Deep-Dive into the Future of Integrated Healthcare - FinancialContent

Jan 28, 2026
pulisher
Jan 28, 2026

What’s Behind The Crash In CVS Stock? - Trefis

Jan 28, 2026
pulisher
Jan 28, 2026

UnitedHealth, Humana, CVS Shares Get Crushed As Trump Administration Proposes Lower-Than-Expected Medicare Insurer Rates - AOL.com

Jan 28, 2026
healthcare_plans CI
$292.05
price up icon 2.64%
healthcare_plans ELV
$338.98
price up icon 2.03%
healthcare_plans HUM
$193.94
price up icon 0.20%
healthcare_plans CNC
$38.46
price down icon 3.66%
healthcare_plans MOH
$131.72
price down icon 25.51%
자본화:     |  볼륨(24시간):